돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1876545생성일: 2026년 10월 26일

N-methyl-2-pyrrolidone → 5-{9-Isobutyl-8-[4-(methylsulfonyl)-1,4-diazepan-1-yl]-6-morpholin-4-yl-9H-purin-2-yl}pyrimidin-2-amine

https://huagongshe.com/reaction/1876545

반응식

참여 물질

역할이름HCID투입량
반응물N-methyl-2-pyrrolidoneHCID 13387—
반응물Methanesulfonyl chlorideHCID 31297—
반응물Hexahydro-1,4-diazepineHCID 68163—
반응물5-(8-Chloro-9-isobutyl-6-morpholino-9H-purin-2-yl)pyrimidin-2-amineHCID 59333549—
용매TriethylamineHCID 8471—
생성물5-{9-Isobutyl-8-[4-(methylsulfonyl)-1,4-diazepan-1-yl]-6-morpholin-4-yl-9H-purin-2-yl}pyrimidin-2-amineHCID 59333660110.9%

반응 조건

온도120 °C

반응 단계

Homopiperazine (130 mg, 1.3 mmol) and N-methylpyrrolidone (1 ml) were added to 5-(8-chloro-9-isobutyl-6-morpholin-4-yl-9H-purin-2-yl)pyrimidin-2-amine (100 mg, 0.26 mmol) and the resulting mixture stirred at 120° C. for 2 hours. The reaction mixture was cooled and partitioned with methylene chloride and water, the organic layer was dried over magnesium sulfate, and the solvent was concentrated under reduced pressure. Triethylamine (110 μl) and mesyl chloride (45 μl, 0.58 mmol) were added to the resulting mixture and the resulting mixture was stirred for 0.5 hours. The reaction mixture was partitioned with ethyl acetate and water and the organic layer was dried over magnesium sulfate. The solvent was evaporated under reduced pressure and the residue was purified by preparative HPLC (column, NOMURA Develosil Combi-RP-5; mobile phase, acetonitrile/water/formic acid) to give the title compound (153 mg, 75%) as a white solid.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08309546B2
출처 데이터셋uspto-grants-2012_11
ORD IDord-cbaf247855bd48caaa18cfafd32bf9ec
출처 메모uspto-grants-2012_11